Endovascular Management of Pelvic Congestion Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
Endovascular embolization: Transcatheter embolization of incompetent ovarian and/or pelvic veins using standard embolic materials according to institutional practice to treat pelvic congestion syndrome.
Study summary
Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS
Eligibility
Primary outcome measure(s)
- Improvement in pelvic pain after endovascular embolization — 6 months
Change in pelvic pain measured using the Visual Analog Scale (VAS, 0-10), comparing baseline with 6-month follow-up. Unit of Measure: VAS score (0-10)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Interventional radiology unit, Sohag university hospital | Sohag | Sohag Governorate | Recruiting |
More Sohag University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07735156 on ClinicalTrials.gov ↗ ← All trials in Egypt